Epidemiology of Noncardiac Surgery Dr. Mohammed Naser.

Slides:



Advertisements
Similar presentations
ANESTHESIA FOR A GERIATRIC PATIENT WITH HEART DISEASE
Advertisements

Dr. Sonia Anand McMaster University
Acquired Heart Disease
Perioperative Issues Dr John Oyston Dept of Medicine Rounds April 15 th 2008.
Stenting Patients Needing Non-Cardiac Surgery
Ryan Hampton January  Risks and benefits of surgery  Timing of surgery  Type of Surgery  Goal is to uncover undiagnosed problems or treat prior.
CARDIAC RISK ASSESSMENT FOR NONCARDIAC SURGERY JOHN HAMATY D.O. SOUTH JERSEY HEART GROUP SJHG.ORG.
Jacobi Ambulatory Care Service Medical Consultation: An Overview Lori A. Lemberg, MD Fall 2012.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
PREOPERATIVE ASSESSMENT OF THE GERIATRIC PATIENT Cheryl Hinners M.D.
Cardiovascular Pre-Operative Evaluation for Non-Cardiac Surgery Jessica Thom PGY-1.
What is Cardiology Clearance? Sheilah Bernard, MD, FACC Director, Cardiac Amb Services Sheilah Bernard, MD, FACC Director, Cardiac Amb Services 9:30-10:00am.
Copyright ©2007 American College of Cardiology Foundation. Restrictions may apply. Fleisher, L. A. et al. J Am Coll Cardiol 2007;50:e159-e242 Cardiac evaluation.
Guidelines for Perioperative Cardiovascular Evaluation for Noncardiac Surgery* A Report of the American College of Cardiology/American Heart AssociationTask.
CABG GUIDELINES SANJAY DRAVID, M.D.. INTRODUCTION ACC/AHA GUIDELINE UPDATE FOR CORONARY ARTERY BYPASS GRAFT SURGERY (JACC 2004; 44: AND CIRCULATION.
Focusing on the Surgical Patient with Cardiac Problems By Kate J. Morse, RN, ACNP-BC, CCRN Nursing2009, March ANCC contact hours Online:
Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery 2007 ACC/AHA and 2009 ESC GUIDELINES.
Perioperative Cardiovascular Evaluation for Noncardiac Surgery By :Mahmoud M Othman MD, Prof of Anesthesia & SICU, Mansoura faculty of Medicine.
Preoperative assessment
Perioperative Risk Assessment - Can You Get It Right?
Perioperative and Consultative Medicine Pamela J. Pride MD, FHM Medical University of South Carolina 2/7/2012.
Exercise Echocardiography Cardiac Issues 2011 Douglass A Morrison, MD, PhD.
ACC/AHA 2007 Update on Perioperative Cardiovascular Evaluation for Noncardiac Surgery Doris Lin, M.D.
Preoperative Cardiac Evaluation Jonathan Hastie January 31, 2006.
PREOPERATIVE EVALUATION
1 Covenants of the Medical Home Neighborhood  How Primary Care Physicians and Specialists can “Choose Wisely”
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
Cardioprotective Agents in the Total Joint Arthroplasty Patient: Are We Doing Enough? Eric Schwenk MD*, Kishor Gandhi MD MPH*, Javad Parvizi MD^, Eugene.
Systemic Hypertension. Systemic blood pressure measures 140/90 mm Hg or higher on at least two occasions a minimum of 1 to 2 weeks apart.
Ian Smith, MD, FRCA Editor, Journal of One-day Surgery, Senior Lecturer in Anaesthesia University Hospital of North Staffordshire Stoke-on-Trent Cardiovascular.
C.H.T Dr.Salarifar 1 Tehran Heart Center Tehran University of Medical Sciences PCI VS CABG M. SALARIFAR, MD.
Perioperative and Consultative Medicine Pamela J. Pride MD, FHM Medical University of South Carolina 2/7/2012.
Indication and contra-indications for cardiac catheterization
Management of Stable Angina SIGN 96
Lecture Title: Lecture Title: Role of anesthesiologist in pre-operative period Lecturer name: Lecturer name: Prof. Ahmed Abdulmoemn Lecture Date:
- To understand the perioperative period term. - To understand the objectives of preoprative visit. - To identify the risk factors in anesthesia. - To.
3/99medslides.com1 Guidelines for Perioperative Cardiovascular Evaluation for Noncardiac Surgery ACC/AHA Task Force JACC 1996; 27: Circulation 1996;
Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.
Perioperative and Consultative Medicine Pamela J. Pride MD, FHM Medical University of South Carolina 2/7/2012.
Pre-operative Cardiovascular Evaluation: Guidelines and More Eric A. Brody MD, FACC Medical Director, NA Cardiology and Medical Services Associate Professor.
Atherosclerotic Disease of the Carotid Artery Atherosclerosis is a degenerative disease of the arteries resulting in plaques consisting of necrotic cells,
Acute Coronary Syndromes Risk-Stratification Pathophysiology Diagnosis Initial Therapy Risk-Stratification Risk-Stratification Invasive vs Conservative.
Preoperative Cardiac Evaluation
1. Dr. Mansoor Aqil Prof. and Consultant Department Of Anaesthesia King Saud University Riyadh 2.
Gregg W. Stone MD for the ACUITY Investigators Gregg W. Stone MD for the ACUITY Investigators A Prospective, Randomized Trial of Bivalirudin in Acute Coronary.
1. Dr. Mansoor Aqil Associate Prof. and Consultant Department Of Anaesthesia King Saud University Riyadh 2.
Indication Of Cardiac Consultation In Noncardiac Surgery.
Gregg W. Stone MD for the ACUITY Investigators A Prospective, Randomized Trial of Bivalirudin in Acute Coronary Syndromes Final One-Year Results from the.
Evaluating the Heart before Non-Cardiac Surgery Dr Rob Stephens Anaesthetist UCLH + UCL.
Dr Cristina Constantin Consultant Cardiologist Princess of Wales Hospital.
Ty J. Gluckman, MD, FACC Providence St. Vincent Heart and Vascular Institute, Portland, Oregon Ciccarone Center for the Prevention of Heart Disease, Johns.
Perioperative Cardiovascular Evaluation SooJoong Kim, MD, PhD. Department of Cardiology, Internal Medicine, Kyunghee University Medical Center.
Dr. Alireza Pournajafian – Assistant Professor of Anesthesia
Cardio-Pulmonary Pre Operative Risk Assessment Andy Shakespeare MD PGY2 Baylor Scott and White IM
Segment 1 Perioperative Risk Assessment. Need Advice – How Low is Low Dear Consult Sages ; I need your help and guidance to provide better service to.
Faramarz Amiri MD IUMS.  Severe carotid disease (defined as >80%) 8–12%  Severe carotid disease (>70%) in those with three vessel or left main coronary.
Role of Anesthesiologist Peri-Operative Period. Lecture Objectives.. Students at the end of the lecture will be able to: a) Obtain a full history and.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate.
Survival Benefits in Higher Risk Patients Coronary Revascularization has Revolutionized the Therapy of Ischemic Heart Disease Acute coronary syndromes.
Choosing Wisely: Cardiology Jeffrey Ziffra D.O. Mercy Medical Center – North Iowa 10/14/2016.
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
CORONARY ARTERY DISEASE
Pre-anesthesia evaluation and preparation of patient
Pre-operative assessment
preoperative evaluation
Single Stage CABG and Peripheral Arterial Bypass for Combined Coronary and Peripheral Arterial Disease Divya Arora, Ashok Chahal and Shamsher Singh Lohchab.
Dr. PJ Devereaux on behalf of POISE Investigators
Dr. PJ Devereaux on behalf of POISE Investigators
Lee A. Fleisher et al. JACC 2014;64:e77-e137
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

Epidemiology of Noncardiac Surgery Dr. Mohammed Naser

Epidemiology of Noncardiac Surgery Cardiac patient undergoing non cardiac surgery can be at risk for major peri operative complication. Perioperative risk…increased sym+,pro inflammatory state hypercoagubility and ocasional post opetative hypoxia

Pre-Op Risk Assessment =

Overview Important Decision points: –Urgent vs Elective Surgery –High risk surgery vs intermediate vs low -Active Cardiac Condition vs non-active Functional capacity on basis of pt ablility To perform certain activities

The Search For High Risk

Methods for Assessing Risk Pre-Operatively Is the surgery emergency PROCEED and manage post operatively according to AHA& ACC guidelines

If the surgery emergency..??

Active/Major Cardiac Conditions Unstable Coronary Conditions Decompensated CHF Significant arrhythmias (i.e. 3 ⁰ HB, new Vtach) Severe Valvular Disease (aortic stenosis >40 mm hg gradient or valve area <1.0cm ₂ )???????

Non-Active Cardiac Factors Intermediate Risk Hx of CHD History of prior CHF Hx of stroke Diabetes Renal insufficiency Minor Risk* Age > 70 Abnormal ECG Nonsinus rhythm Uncontrolled systolic BP * Not associated with cardiac risk

Six Independent predictors of cardiac risk 1)ischemic heart disease 2)congestive heart failure 3) cerebrovascular disease 4) high risk surgery (AAA, orthopedic sx) 5) pre-operative insulin tx for diabetes 6) preoperative creatinine for creat > 2 mg/dL Lee et al

Functional capacity

Functional Capacity Functional status has shown to be a reliable periop and long-term predictor of cardiac events MET: metabolic equivalent resting oxygen consumption of 70 kg, 40 yr old man at rest Periop risk is increased if person cannot > 4 METS

1 MET 4 MET 10 MET Eat, dress DO light house work i.e. Washing dishes Climb a flight of stairs Run a short distances Moderate recreational golf, dancing, baseball Strenuous sports swimming, basketball

The Trump Card: Functional Capacity Perioperative cardiac risk is increased in patients unable to exercise 4 METs Functional capacity can be estimated in the office –Energy expenditure for eating, dressing, walking around house, dishwashing ranges from 1-4 METs –Climbing a flight of stairs, running a short distance, scrubbing floors, and golf ranges from 4-10 METs –Swimming and singles tennis exceeds 10 METs

Surgery Risk Type TypeCardiac riskexamples High> 5%Aortic, peripheral vasc sx Intermediate risk1-5%Intraperitoneal Intrathoracic Carotid End Head and neck Orthopedic Sx Prostate Sx Low<1%Endoscopic procedures Superficial Cataract Sx Breast Sx Ambulatory Sx

Surgery-Specific Risk: High Risk* Major emergency surgery Vascular surgery including: aortic surgery, infra-inguinal bypass Prolonged surgery with large fluid shifts or blood loss * Reported risk of cardiac death or nonfatal MI >5%

Stepwise Approach Step 1: Determine urgency of surgery Step 2: Active cardiac condition?-→test Step 3: Undergoing low-risk surgery? < 1%* Step 4: Good functional capacity? * Combined morbidity and mortality < 1% even in high risk patients

The Catheterization Questions to Ask Yourself Does this patient have symptomatic coronary disease that will have a mortality benefit from revascularization now? Am I willing to send the patient to CABG? Am I doing this just to know the anatomy?

Is pre-op coronary revasc advantageous? If high risk surgery and patient has active cardiac issue Functional test and perfusion Imaging and if L main 50% or 3 VD, 2VD + LAD Prox, LVEF < 20%, aortic stenosis – consider revasc pre-op

STENTS If upcoming Sx is known then PTCA alone or BMS with 4-6 wks dual antiplatelet tx after If received DES.... –1) postpone sx until > 12 months, –2) do sx on both asa+clop – 3) do sx on single ap tx

Use of a DES for coronary revascularization before imminent or planned non cardiac sx that will necessitate d/c of antiplatelet agents is not recommended

Medical tx 1) beta blockers-if on keep them if not.... 2) Statins continue, ? Start -need randomized trials

Other Issues DVT/PE prophylaxis Anesthetic technique-volatile agent with general anesthetic - ↓ troponin ↑ LV function >> propofol, midazolam, balanced anesthesia (Grade B) No evidence that epidural anesthesia >>general anesthesia for cardiac outcomes Routine troponin monitoring not recommended

Surveillance for Perioperative Myocardial Infarction ECGs –All intermediate and high-risk patients should get a post-op ECG. –As need for signs or symptoms of ischemia Troponin / CK –In patients with signs or symptoms of ischemia –Do not do screening biomarkers

High Risk Features Severe obstructive or restrictive pulmonary disease Diabetes Renal impairment Anemia, polycythemia, thrombocytosis

PCI pre-op ST-elevation MI Unstable angina Non ST elevation MI

2007 ACC/AHA Perioperative Guidelines

Take Home Messages

Unstable syndromes require management prior to surgery. Look for –Unstable angina –Signs of heart failure –Stenotic valve lesions –Ventricular arrhythmias Functional tolerance is the best single predictor of outcome Be very specific in your history (one step at at time, regular or slow pace, etc) If patient on beta blockers & statins continue them, more trials to mandate them PCI/CABG only if patient needs it independent of surgery. Think twice because of stent data and delays.